With a market cap of $52.7 billion, The Allstate Corporation (ALL) is one of the largest publicly held personal lines insurers in the United States. Operating through five business segments, the company offers a wide range of property, casualty, life, health, and protection products to individuals, households, and employers across the U.S. and Canada. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Allstate fits this criterion perfectly. Allstate delivers its services through exclusive and independent agents, contact centers, and digital platforms, while also providing innovative protection plans and data-driven solutions.

Despite this, shares of the Northbrook, Illinois-based company have declined 6.8% from its 52-week high of $214.76. ALL stock has risen 1.6% over the past three months, underperforming the Nasdaq Composite’s ($NASX) 11.7% increase over the same time frame. 

In the longer term, ALL stock is up 3.6% on a YTD basis, lagging behind NASX’s 13.3% gain. Moreover, shares of the insurer have gained nearly 8% over the past 52 weeks, compared to NASX’s 29.6% return over the same time frame. 

Despite a few fluctuations, the stock has been trading mostly above its 200-day moving average since last year. 

Allstate shares rose 5.7% following its Q2 2025 results on Jul. 30 as the insurer posted adjusted EPS of $5.94, far surpassing analyst expectations. The strong performance was driven by a sharp turnaround in its property-liability segment, where underwriting income jumped to $1.28 billion from a loss a year earlier, and the underlying combined ratio improved significantly to 79.5%. Additionally, higher net investment income of $754 million reinforced investor confidence.

However, rival The Hartford Insurance Group, Inc. (HIG) has outpaced ALL stock. Shares of Hartford Insurance Group have returned 19.6% on a YTD basis and 11.9% over the past 52 weeks. 

Despite the stock’s underperformance relative to the Nasdaq, analysts remain moderately optimistic on Allstate. ALL stock has a consensus rating of “Moderate Buy” from 23 analysts in coverage, and the mean price target of $231.79 is a premium of 15.8% to current levels.